PLUMP ANDREW STEWART (President, R&D) sold 7.0% of their position (19.65K shares) of TAKEDA PHARMACEUTICAL CO LTD on the open market
Open‑market sale worth $363.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/21/2026ACC: 0001493152-26-039693
DirectorOfficer· President, R&D
Since Mar 2026
-19.65K
Net shares
Net seller
$363.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
19.65K disposed
Non-Derivative Transactions1
American Depositary Shares
Indirect
Shares
−19.65K
Price / share
$18.49
Trade value
$363.35K
% of position
7.0%
8/19/2026
281.31K→261.66K
Total
Net shares
−19.65K
Net value
-$363.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Indirect | 8/19/2026 | S · Sale | −19.65K | $18.49 | $363.35K | 7.0% | 281.31K | 261.66K |
| Total | −19.65K | -$363.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares
DirectShares owned766.57K
Total
766.57K direct766.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares | 766.57K | Direct |
| Total | 766.57K | 766.57K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported